Ohio State oncologist Ning Jin and other clinicians are seeing an alarming rise in late-stage colorectal cancer among people in their 30s and 40s. These patients are decades younger than the historical norm, their tumors often appear lower in the digestive tract and sometimes resist standard therapies. Jin notes that even when younger patients receive more aggressive chemotherapy or surgery, their outcomes are not necessarily better. Colorectal cancer is now the leading cancer killer for people under 50, even as mortality declines in older groups.
Genetics account for some cases: roughly 20% of patients carry inherited risk markers, such as mutations tied to Lynch syndrome. But that leaves about 80% unexplained by hereditary factors, pushing researchers to look at environmental and generational shifts that could be increasing risk.
Dr. John Marshall, head of clinical research at Georgetown’s Lombardi Cancer Center, describes the change as generational. When he began his practice more than 30 years ago, he saw essentially no patients under 50 with colon cancer; today, nearly half of his clinic’s colon-cancer patients are under age 50. He and others also report a shift in tumor location, with more early-onset cancers appearing nearer the rectum. The speed of these changes suggests influences tied to modern life rather than slow genetic evolution.
Investigators point to several likely contributors: greater consumption of ultra-processed foods, exposure to plastics and industrial chemicals that can leach into food and water, and more sedentary lifestyles. A prevailing theory links these exposures to changes in the gut microbiome—the vast community of bacteria, viruses and other microorganisms that live in the digestive tract. If that microbial ecosystem is disturbed, it may promote chronic inflammation, weaken protective barriers, or generate toxins that damage DNA, creating conditions favorable to tumor development.
Researchers use the soil metaphor to explain the microbiome’s role: like soil, the gut’s microbial community shapes how the body interacts with the environment. If that “soil” is altered by diet, pollutants or other exposures, it may help nurture disease. Some chemicals and microbes can erode the gut’s mucus layer, the partial barrier that keeps harmful agents from contacting the intestinal lining. When that shield is compromised, tissues become vulnerable to inflammation and to biochemical insults that can lead to DNA damage—processes implicated in cancer formation.
Evidence linking microbes directly to colorectal cancer is mounting but complex. A notable finding implicates colibactin, a DNA-damaging toxin produced by certain strains of E. coli and other bacteria; researchers have associated colibactin-producing microbes with colon cancers in younger patients, suggesting a possible microbial driver. Yet measuring an individual’s microbiome “health” is still problematic: scientists lack reliable, standardized tests to define a healthy versus risky microbiome or to show how best to restore a beneficial community.
Because multiple environmental exposures, lifestyle factors and microbes probably interact to increase risk, researchers emphasize the need for controlled, longitudinal studies to disentangle cause and effect and to establish when and how interventions might prevent cancer. Until causal pathways become clearer and diagnostic tools improve, clinicians and patients must rely on known risk indicators: family history, symptoms such as rectal bleeding or changes in bowel habits, and current screening recommendations. Preventive screening is generally recommended and typically covered by insurance starting at age 45, and advocates urge younger adults with relevant family histories or symptoms to discuss testing with their doctors.
In short, the microbiome is a promising focus in the search for why colorectal cancer is rising in younger adults, but many questions remain. Researchers continue to probe how modern diets, chemicals and lifestyles reshape gut microbes and how those changes might translate into increased cancer risk.